CO6870003A2 - Vacunas bovinas y métodos - Google Patents

Vacunas bovinas y métodos

Info

Publication number
CO6870003A2
CO6870003A2 CO13268129A CO13268129A CO6870003A2 CO 6870003 A2 CO6870003 A2 CO 6870003A2 CO 13268129 A CO13268129 A CO 13268129A CO 13268129 A CO13268129 A CO 13268129A CO 6870003 A2 CO6870003 A2 CO 6870003A2
Authority
CO
Colombia
Prior art keywords
methods
bovine vaccines
vaccines
bovine
Prior art date
Application number
CO13268129A
Other languages
English (en)
Inventor
Eric Springer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO6870003A2 publication Critical patent/CO6870003A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CO13268129A 2011-06-10 2013-11-14 Vacunas bovinas y métodos CO6870003A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161495591P 2011-06-10 2011-06-10

Publications (1)

Publication Number Publication Date
CO6870003A2 true CO6870003A2 (es) 2014-02-20

Family

ID=47296754

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13268129A CO6870003A2 (es) 2011-06-10 2013-11-14 Vacunas bovinas y métodos

Country Status (6)

Country Link
US (1) US9364527B2 (es)
CA (1) CA2836805C (es)
CO (1) CO6870003A2 (es)
MX (1) MX345704B (es)
PE (1) PE20140576A1 (es)
WO (1) WO2012170753A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578205A1 (en) 2010-08-06 2019-12-11 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
RU2013120302A (ru) 2010-10-01 2014-11-20 Модерна Терапьютикс, Инк. Сконструированные нуклеиновые кислоты и способы их применения
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
LT2791160T (lt) 2011-12-16 2022-06-10 Modernatx, Inc. Modifikuotos mrnr sudėtys
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9192651B2 (en) 2012-04-02 2015-11-24 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
WO2014028429A2 (en) 2012-08-14 2014-02-20 Moderna Therapeutics, Inc. Enzymes and polymerases for the synthesis of rna
WO2014081507A1 (en) 2012-11-26 2014-05-30 Moderna Therapeutics, Inc. Terminally modified rna
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
EP2971010B1 (en) 2013-03-14 2020-06-10 ModernaTX, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
US10849920B2 (en) 2015-10-05 2020-12-01 Modernatx, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
EP3407734B1 (en) 2016-01-25 2023-03-08 Signify North America Corporation Biosecurity system for an agricultural dwelling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501213A (en) 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
ATE533506T1 (de) * 2002-08-26 2011-12-15 Pfizer Prod Inc Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
US7563449B2 (en) 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
UY29915A1 (es) 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
MX349720B (es) 2008-06-27 2017-08-09 Zoetis Services Llc Composiciones adyuvantes novedosas.

Also Published As

Publication number Publication date
WO2012170753A2 (en) 2012-12-13
MX2013014485A (es) 2014-03-21
US20140105930A1 (en) 2014-04-17
CA2836805A1 (en) 2012-12-13
MX345704B (es) 2017-02-10
US9364527B2 (en) 2016-06-14
PE20140576A1 (es) 2014-05-24
WO2012170753A3 (en) 2014-05-08
CA2836805C (en) 2023-03-07

Similar Documents

Publication Publication Date Title
CO6870003A2 (es) Vacunas bovinas y métodos
CO6930343A2 (es) Conjunto conntenedor y método asociado
BR112014000238A2 (pt) método e artigo
HK1243344A1 (zh) 抗體製劑和方法
DK3321287T3 (da) Fusionsproteiner og kombinationsvacciner
DK2794654T3 (da) Anti-phf-tau-antistoffer og deres anvendelser
DK2850202T3 (da) Fremgangsmåder og grupper
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
BR112013001592A2 (pt) artigo e método
BR112013032426A2 (pt) composições probióticas e métodos
FI20116190L (fi) Hissijärjestely ja menetelmä
BR112014007958A2 (pt) método
BR112014000317A2 (pt) conjunto e sistema
BR112013010847A2 (pt) artigo e método
BR112014010450A2 (pt) composição e método
BR112014001237A2 (pt) método
SMT201600082B (it) Vaccino pcsk9
BR112014001765A2 (pt) método
ZA201400562B (en) Axmi205 variant proteins and methods for their use
BR112013029674A2 (pt) dispositivo para manuseio e método
BR112013022766A2 (pt) método de administração de d-pirfenidona e kit
BR112013022411A2 (pt) artigo absorvente e método para preparar um artigo absorvente
BR112014009795A2 (pt) método
BR112013016641A2 (pt) artigo e método
BR112013020287A2 (pt) projetor e método de autenticação